MP24-12 ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER IS ASSOCIATED WITH THE RISK OF SUBSEQUENT ALZHEIMER'S DISEASE BUT NOT WITH VASCULAR DEMENTIA | Zendy

AI Assistant Blog Pricing

MP24-12 ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER IS ASSOCIATED WITH THE RISK OF SUBSEQUENT ALZHEIMER'S DISEASE BUT NOT WITH VASCULAR DEMENTIA

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.